Evidence map›Paper›PMID 30151974›Full record

ArticleAnnals of the New York Academy of Sciences2018

Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs.

Kyly C Whitfield, Megan W Bourassa, Bola Adamolekun, Gilles Bergeron, Lucien Bettendorff, Kenneth H Brown, Lorna Cox, Aviva Fattal-Valevski, Philip R Fischer, Elizabeth L Frank and 10 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Annals of the New York Academy of Sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 150 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed, 4 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05480943 completednot on this mapstarted 2022, after this paper: background citation

Prevalence of Thiamine Deficiency in Hospitalized Non-Alcoholic Veterans

TypeobservationalSponsorVA Office of Research and DevelopmentRan2022 to 2024Enrolled206ConditionsThiamine Deficiency, Thiamine Deficiency, SequelaeArmsThiamine repletion
NCT06223360 phase2active not recruitingnot on this mapstarted 2024, after this paper: background citation

A Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo- Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

TypeinterventionalSponsorAlzheimer's Disease Cooperative Study (ADCS)Ran2024 to 2027Enrolled406ConditionsAlzheimer DiseaseArmsLow Dose Benfotiamine, High Dose Benfotiamine, Placebo
3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 4 syntheses or guidelines pooled it, 311 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 19 institutions in 9 countries.

Kyly C WhitfieldDepartment of Applied Human Nutrition, Mount Saint Vincent University, Halifax, Nova Scotia, Canada.
Megan W BourassaThe Sackler Institute for Nutrition Science, The New York Academy of Sciences, New York, New York.
Bola AdamolekunUniversity of Tennessee Health Science Center, Memphis, Tennessee.
Gilles BergeronThe Sackler Institute for Nutrition Science, The New York Academy of Sciences, New York, New York.
Lucien BettendorffLaboratory of Neurophysiology, GIGA-Neurosciences, University of Liège, Liège, Belgium.
Kenneth H BrownBill & Melinda Gates Foundation, Seattle, Washington.
Lorna CoxMedical Research Council Elsie Widdowson Laboratory, Cambridge, United Kingdom.
Aviva Fattal-ValevskiTel Aviv Medical Center, Dana-Dwek Children's Hospital, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Philip R FischerMayo Clinic, Rochester, Minnesota.
Elizabeth L FrankUniversity of Utah and ARUP Laboratories, Salt Lake City, Utah.
Laurent HifflerDoctors without Borders (MSF), Barcelona, Spain.
Lwin Mar HlaingNational Nutrition Center, Ministry of Health and Sports, Myanmar.
Maria Elena JefferdsCenters for Disease Control and Prevention, Atlanta, Georgia.
Hallie KapnerIndependent contractor, New York, New York.
Sengchanh KounnavongThe Lao Tropical and Public Health Institute, Ministry of Health, Vientiane, Lao PDR.
Maral P S MousaviDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts.
Daniel E RothHospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
Maria-Nefeli TsaloglouDiagnostics for All Inc., Salem, Massachusetts.
Frank WieringaInstitut de Recherche pour le Developpment, Montpellier, France.
Gerald F CombsJean Mayer USDA Human Nutrition Research Center, Tufts University, Boston, Massachusetts.
New York Academy of Sciences · USARUP Laboratories (United States) · USBill & Melinda Gates Foundation · USCenters for Disease Control and Prevention · USDiagnostics For All · USHarvard University Press · USIndependent Sector · USInstitut de Recherche pour le Développement · FRMayo Clinic · USMédecins Sans Frontières · ESMedical Research Council · GBMinistry of Health · LAMinistry of Health and Sports · MMMount Saint Vincent University · CASickKids Foundation · CATel Aviv University · ILTufts University · USUniversity of Liège · BEUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thiamine is an essential micronutrient that plays a key role in energy metabolism. Many populations worldwide may be at risk of clinical or subclinical thiamine deficiencies, due to famine, reliance on staple crops with low thiamine content, or food preparation practices, such as milling grains and washing milled rice. Clinical manifestations of thiamine deficiency are variable; this, along with the lack of a readily accessible and widely agreed upon biomarker of thiamine status, complicates efforts to diagnose thiamine deficiency and assess its global prevalence. Strategies to identify regions at risk of thiamine deficiency through proxy measures, such as analysis of food balance sheet data and month-specific infant mortality rates, may be valuable for understanding the scope of thiamine deficiency. Urgent public health responses are warranted in high-risk regions, considering the contribution of thiamine deficiency to infant mortality and research suggesting that even subclinical thiamine deficiency in childhood may have lifelong neurodevelopmental consequences. Food fortification and maternal and/or infant thiamine supplementation have proven effective in raising thiamine status and reducing the incidence of infantile beriberi in regions where thiamine deficiency is prevalent, but trial data are limited. Efforts to determine culturally and environmentally appropriate food vehicles for thiamine fortification are ongoing.

Indexed as

Dietary SupplementsFood, FortifiedPublic HealthGlobal HealthHumansPrevalenceRisk FactorsThiamine Deficiencyberiberierythrocyte transketolaseLMICnutritionthiamine deficiencythiamine diphosphate

Identifiers

PMID30151974
PMCPMC6392124
OpenAlexW2889058844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.